Agendia and Genecast Biotechnology Partner to Launch MammaPrint(R) and BluePrint(R) in China
For the first time, early-stage breast cancer patients and their physicians in China can access clinically validated and prospectively proven tests for breast cancer risk of recurrence and molecular subtyping IRVINE, Calif. and AMSTERDAM and BEIJING, Se... Diagnostics, Personalized Medicine, Oncology, Product Launch Agendia, MammaPrint, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2018 Category: Pharmaceuticals Source Type: news

1st Wireless, Handheld, FDA-approved Ultrasound Device to Offer Live Demos at FMX (Family Medicine Experience) 2018, Booth #722
Wireless, app-based technology is positioning the ultrasound to become as ubiquitous as a stethoscope for general practitioners ROSEVILLE, Calif., Sept. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Healcerion today announced the SONON 300L wil... Devices, Product Launch Healcerion, wireless, ultrasound imaging, ultrasound, smartphone (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2018 Category: Pharmaceuticals Source Type: news

TranS1(R) Announces NICE Guidance for Approval of AxiaLIF(R) in the UK's National Health System (NHS)
NICE's Positive Recommendation for the Transaxial Interbody Lumbosacral Fusion describing the Anterior Retroperitoneal Presacral Approach is based on AxiaLIF clinical evidence WILMINGTON, N.C., Sept. 18, 2018 -- (Healthcare Sales & Marketing Network) -... Devices, Orthopaedic, Neurosurgery, Reimbursement TranS1, AxiaLIF, lumbosacral fusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2018 Category: Pharmaceuticals Source Type: news

Anti-migraine Head Patch - HeadaTerm - Receives FDA Clearance
VANCOUVER, British Columbia, Sept. 17, 2018 -- (Healthcare Sales & Marketing Network) -- WAT Medical's innovative technology to treat all primary headaches, HeadaTerm, received its FDA clearance in September 2018. This product, already approved by CE, HC,... Devices, Neurology, FDA WAT Medical Enterprise, HeadaTerm, neuromodulation, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 17, 2018 Category: Pharmaceuticals Source Type: news

U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
U.S. Commercial Launch of Cash-Pay Product Anticipated in Mid-2019 DULUTH, Ga., Sept. 17, 2018 -- (Healthcare Sales & Marketing Network) -- Sebacia, Inc., a privately held, commercial stage dermatology and aesthetics company, today announced that the U... Devices, Dermatology, FDA Sebacia, Sebacia Microparticles, acne (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 17, 2018 Category: Pharmaceuticals Source Type: news

Halozyme Announces Approval Of Subcutaneous Formulation Of Trastuzumab (Herceptin(R)) In Canada
SAN DIEGO, Sept. 17, 2018 -- (Healthcare Sales & Marketing Network) -- Halozyme Therapeutics, Inc. (NASDAQ :HALO ) today announced that Roche has received approval from Health Canada for a subcutaneous (SC) formulation of trastuzumab (Herceptin SC) for th... Biopharmaceuticals, Oncology, Regulatory Halozyme Therapeutics, Genentech, trastuzumab, Herceptin, hyaluronidase (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 17, 2018 Category: Pharmaceuticals Source Type: news

Livongo Announces First Cellular-Enabled Blood Pressure Monitoring System in U.S.
Cellular Connectivity Enables Home Checking & Reporting, Reduces 'White Coat' Issues MOUNTAIN VIEW, Calif., Sept. 17, 2018 -- (Healthcare Sales & Marketing Network) -- Livongo Health, the leading consumer digital health company empowering people with c... Devices, Cardiology, Product Launch Livongo Health, Cellular-Enabled, Blood Pressure Monitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 17, 2018 Category: Pharmaceuticals Source Type: news

CartiHeal Performs First Hungarian Case in the Agili-C(TM) Implant IDE Multinational Pivotal Study
KFAR SABA, Israel and BUDAPEST, Hungary, Sept. 17, 2018 -- (Healthcare Sales & Marketing Network) -- CartiHeal, developer of the Agili-C implant for the treatment of joint surface lesions, and the Principle Investigator Professor László Hang... Devices, Orthopaedic CartiHeal, Agili-C , osteochondral defects, osteoarthritic joints (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 17, 2018 Category: Pharmaceuticals Source Type: news

ORIC Pharmaceuticals Appoints Pratik Multani, MD, as Chief Medical Officer
SAN FRANCISCO, Sept. 17, 2018 -- (Healthcare Sales & Marketing Network) -- ORIC Pharmaceuticals, a clinical-stage oncology company focused on discovery and development of novel therapies against treatment-resistant cancers, today announced that Dr. Pratik... Biopharmaceuticals, Oncology ORIC Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 17, 2018 Category: Pharmaceuticals Source Type: news

Gala Presents Positive Results from First-In-Human Clinical Trial of RheOx(TM) in Chronic Bronchitis at the European Respiratory Society
Favorable safety profile RheOx treatment resulted in clinical improvement as measured by Quality of Life scores, with treatment effect maintained at 12-month follow-up Improvement in airway biopsies and imaging MENLO PARK, Calif., Sept. 17, 2018 -... Biopharmaceuticals Gala Therapeutics, RheOx, chronic bronchitis, Bronchial Rheoplasty (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 17, 2018 Category: Pharmaceuticals Source Type: news

Samumed And United Therapeutics Announce North American License Agreement For Samumed's IPF Drug Candidate
SAN DIEGO and SILVER SPRING, Md., Sept. 17, 2018 -- (Healthcare Sales & Marketing Network) -- Samumed LLC has entered an exclusive license agreement with United Therapeutics Corporation (Nasdaq :UTHR ) for North American rights to Samumed's SM04646, being... Biopharmaceuticals, Licensing United Therapeutics, Samumed, idiopathic pulmonary fibrosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 17, 2018 Category: Pharmaceuticals Source Type: news

Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
Acquisition Adds Fast-Acting Neurotoxin Programs with 2 to 4-Week Duration to Allergan's Best-in-Class Medical Aesthetics Portfolio and Pipeline DUBLIN and NEWPORT BEACH, Calif., Sept. 14, 2018 -- (Healthcare Sales & Marketing Network) -- Allergan plc ... Biopharmaceuticals, Dermatology, Mergers & Acquisitions Allergan, Bonti, botulinum neurotoxin, BoNT/E, botulinum (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 14, 2018 Category: Pharmaceuticals Source Type: news

Endotronix Raises $45 Million in Series D Financing for the Treatment of Heart Failure
LISLE, Ill., Sept. 14, 2018 -- (Healthcare Sales & Marketing Network) -- Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure, today announced the close of a Series D financing round totaling $45 millio... Devices, Cardiology, Venture Capital Endotronix, Cordella, Heart Failure System, wireless, pulmonary artery sensor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 14, 2018 Category: Pharmaceuticals Source Type: news

CASI Pharmaceuticals Announces $48.5 Million Private Placement
ROCKVILLE, Md., Sept. 14, 2018 -- (Healthcare Sales & Marketing Network) -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innova... Biopharmaceuticals, Venture Capital CASI Pharmaceuticals, Spectrum Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 14, 2018 Category: Pharmaceuticals Source Type: news

Healogics, Inc. Names Michael Fogarty as New Chief Operating Officer
JACKSONVILLE, Fla., Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Healogics®, the nation's wound expert, today announced that it has appointed Michael Fogarty to serve as Chief Operating Officer. He will be replacing Greg Martin who will... Devices, Wound Care, Personnel Healogics, Wound Care Center (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

Olympus Introduces EZ Shot 3 Plus 25 G EUS Needle with Enhanced Maneuverability for Uncompromised Access to Any Lesion, Consistent Performance to Potentially Reduce Procedural Costs and Procedure Time
Entire EZ Shot 3 Plus Line-Up Now Cleared for Fine Needle Biopsy CENTER VALLEY, Pa., Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgic... Devices, Oncology, FDA, Product Launch Olympus Medical Systems, EZ Shot 3 Plus, EZ Shot, fine needle biopsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

Mylan Adds to Cardiovascular Portfolio With Launch of First Generic of Brevibloc(R) Injection in Single-Dose Bags
Esmolol Hydrochloride in Sodium Chloride Injection is used to control heart rate HERTFORDSHIRE, England and PITTSBURGH, Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Global pharmaceutical company Mylan N.V. (NASDAQ : MYL ) today announced... Biopharmaceuticals, Generics, Product Launch Mylan, Esmolol, Brevibloc (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves CroFab(R) Product Improvements
Updated label describes extended shelf life and removal of mercury WEST CONSHOHOCKEN, Pa., Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- BTG plc (LSE : BTG ) announced that the US Food & Drug Administration (FDA) has approved updating the... Biopharmaceuticals, FDA BTG, CroFab, Crotalidae Polyvalent Immune Fab, antivenom, pit viper (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

IFM Therapeutics, LLC Appoints John Leonard, M.D. to Board of Directors
Seasoned industry leader to provide expert counsel to help guide strategic growth of IFM Therapeutics, LLC BOSTON, Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- IFM Therapeutics, LLC (IFM), a privately held biopharmaceutical company focus... Biopharmaceuticals, Personnel IFM Therapeutics, innate immune system (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

XACT Robotics Receives CE Mark for Its Robotics Navigation System for Percutaneous Procedures
Company closes $5 million in round C investment First clinical center of excellence using the XACT system launched at Hadassah Medical Center CAESAREA, Israel, Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- XACT Robotics, a pioneer in ... Devices, Regulatory, Venture Capital XACT Robotics, XACT image guided, robotic navigation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy
TARRYTOWN, N.Y., Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ : REGN ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Appli... Biopharmaceuticals, Ophthalmology Regeneron Pharmaceuticals, EYLEA, aflibercept, diabetic retinopathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

Ardelyx Submits New Drug Application for U.S. Marketing Authorization of Tenapanor for IBS-C to U.S. Food and Drug Administration
FREMONT, Calif., Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Ardelyx, Inc. (Nasdaq : ARDX ), today announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting U.S. marketing authoriz... Biopharmaceuticals, Gastroenterology Ardelyx, tenapanor, IBS-C, irritable bowel syndrome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

AbbVie Announces Patient-Reported Outcomes Data from Three Pivotal Phase 3 Studies of Risankizumab, Showing Significant Improvements in Health-Related Quality of Life for Patients with Psoriasis
Pooled analyses from ultIMMa-1 and ultIMMa-2 studies showed significantly more patients treated with risankizumab were symptom-free (psoriasis symptom scale [PSS] score of 0) compared to placebo and STELARA® (ustekinumab) after 16 weeks and at one year... Biopharmaceuticals, Dermatology AbbVie, Risankizumab, psoriasis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

Targovax Strengthens Management Team With the Appointment of Torbjørn Furuseth as CFO; Erik Digman Wiklund to become CBO
OSLO, Norway, Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, ... Biopharmaceuticals, Oncology, Personnel Targovax (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

Dale(R) Introduces New Hold-n-Place(R) General Purpose Securement Products
Proprietary Devices Provide Trusted Securement for a Wide Variety of Applications FRANKLIN, Mass., Sept. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Dale Medical Products, Inc. (Dale), the company known for its high quality, patient-friendly ... Devices, Product Launch Dale Medical Products, Hold-n-Place (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2018 Category: Pharmaceuticals Source Type: news

Dr. Jeff Balser Named to Varian Board of Directors
PALO ALTO, Calif., Sept. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE : VAR ) today announced that Jeffrey R. Balser, MD, PhD, president and chief executive officer at Vanderbilt University Medical Center and dean of Vanderbilt Unive... Devices, Oncology, Personnel Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2018 Category: Pharmaceuticals Source Type: news

Sutro Taps Worsley as Chief Business Officer; Names Fitzpatrick as People and Communications Chief
SOUTH SAN FRANCISCO, Sept. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Sutro Biopharma, Inc., has appointed Stephen Worsley as chief business officer and has named Linda Fitzpatrick to the newly-created post of chief people and communications of... Biopharmaceuticals, Oncology, Personnel Sutro Biopharma, XpressCF, antibody drug conjugate (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2018 Category: Pharmaceuticals Source Type: news

Biohaven Announces Submission of IND for BHV-3500, Third-Generation, Small Molecule CGRP-Receptor Antagonist for the Treatment of Migraine
BHV-3500 is the first intranasal (IN) formulation of a small molecule calcitonin gene-related peptide (CGRP) receptor antagonist to be advanced for human dosing in clinical trials NEW HAVEN, Conn., Sept. 12, 2018 -- (Healthcare Sales & Marketing Network... Biopharmaceuticals, Neurology, FDA Biohaven Pharmaceutical, rimegepant, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2018 Category: Pharmaceuticals Source Type: news

Exact Imaging Announces Health Canada Approval for its FusionVu(TM) Application for Micro-Ultrasound/MRI Fusion
ExactVu™ micro-ultrasound platform - - now with FusionVu - - enables the highest real-time resolution for targeted prostate imaging and biopsy TORONTO, Sept. 12, 2018 -- (Healthcare Sales & Marketing Network) - Exact Imaging (www.exactimaging.com), th... Devices, Radiology, Regulatory Exact Imaging, ExactVu, FusionVu, micro-ultrasound (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2018 Category: Pharmaceuticals Source Type: news

ExoCoBio Inc. raises $26.7M in Series B Funding
The 4th largest funded exosome startup in the world To help advance its exosome pharmaceutical R&D and cosmeceutical business SEOUL, South Korea, Sept. 12, 2018 -- (Healthcare Sales & Marketing Network) -- ExoCoBio Inc. announced that it recently ra... Biopharmaceuticals, Venture Capital ExoCoBio , exosome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2018 Category: Pharmaceuticals Source Type: news

Biohaven Appoints Bob Repella to Board of Directors
NEW HAVEN, Conn., Sept. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE : BHVN ) today announced the appointment of Robert (Bob) Repella to its Board of Directors. Mr. Repella has extensive experien... Biopharmaceuticals, Neurology, Personnel Biohaven Pharmaceutical, CGRP receptor antagonist, glutamate modulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2018 Category: Pharmaceuticals Source Type: news

FDA to Review Supplemental Biologics License Application for Praluent(R) (alirocumab)Injection as Potential Treatment to Reduce Major Adverse Cardiovascular Events
Last month, FDA also approved Praluent label update for some patients currently requiring LDL apheresis therapy TARRYTOWN, N.Y. and PARIS, Sept. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ : REGN) and S... Biopharmaceuticals, Cardiology, FDA Regeneron Pharmaceuticals, Praluent, alirocumab, PCSK9 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2018 Category: Pharmaceuticals Source Type: news

Codiak BioSciences Names Robert M. Brenner, M.D. Executive Vice President, Research and Development
CAMBRIDGE, Mass., Sept. 11, 2018 -- (Healthcare Sales & Marketing Network) -- Codiak BioSciences, Inc., the leading exosome therapeutics company, today announced the appointment of Robert M. Brenner, M.D. as Executive Vice President and Head of Research a... Biopharmaceuticals, Personnel Codiak BioSciences, exosome, exosome therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 11, 2018 Category: Pharmaceuticals Source Type: news

Andrew Cheng, MD, PhD Joins Akero Therapeutics as President and Chief Executive Officer
Akero's lead program AKR-001 to advance into Phase 2 clinical studies in 2019 Jonathan Young to serve as Executive Vice President and Chief Operating Officer CAMBRIDGE, Mass., Sept. 11, 2018 -- (Healthcare Sales & Marketing Network) -- Akero Therape... Biopharmaceuticals, Personnel Akero Therapeutics, non-alcoholic steatohepatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 11, 2018 Category: Pharmaceuticals Source Type: news

Vertos Medical Announces MILD(R) Procedure Long-term Safety and Efficacy Data
Results from CMS-approved study demonstrate clinically meaningful and statistically significant improvements in mobility and reductions in pain at two-year follow-up ALISO VIEJO, Calif., Sept. 11, 2018 -- (Healthcare Sales & Marketing Network) -- Verto... Devices, Orthopaedic, Neurosurgery Vertos Medical, lumbar spinal stenosis, MiDAS ENCORE, mild lumbar decompression (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 11, 2018 Category: Pharmaceuticals Source Type: news

Philips launches Ingenia Ambition X 1.5T MR with industry-first fully sealed magnet for more productive, helium-free operations
Ingenia Ambition X combines fully sealed BlueSeal magnet technology and workflow innovations for a step-change in productivity This launch represents the continuous improvement to the Philips digital MR portfolio of systems, healthcare informatics and s... Devices, Radiology, Product Launch Royal Philips, Ingenia Ambition X, MR, BlueSeal magnet, imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 11, 2018 Category: Pharmaceuticals Source Type: news

Healogics iSupply Provides New Cost Reduction and Quality Opportunity for Hospitals
This first of its kind program provides hospital partners with solutions to better manage total cost of care and quality outcomes related to wound care products JACKSONVILLE, Fla., Sept. 10, 2018 -- (Healthcare Sales & Marketing Network) -- Healogics&r... Devices, Wound Care, Product Launch Healogics, iSupply (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 10, 2018 Category: Pharmaceuticals Source Type: news

Lilly Announces Initiation of IXORA-R Head-to-Head Trial Comparing Taltz(R) and Tremfya(R) in Patients with Moderate-to-Severe Plaque Psoriasis
INDIANAPOLIS, Sept. 10, 2018 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE : LLY ) announced today the initiation of the IXORA-R head-to-head (H2H) clinical trial, designed to evaluate superiority between Taltz® (ixekizumab)... Biopharmaceuticals Eli Lilly, Taltz, ixekizumabd, Tremfya, guselkumab, psoriasis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 10, 2018 Category: Pharmaceuticals Source Type: news

Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer
SAN DIEGO, Sept. 10, 2018 -- (Healthcare Sales & Marketing Network) -- Biocept, Inc. (NASDAQ : BIOC ), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of pa... Diagnostics, Oncology, Personnel Biocept, liquid biopsy, Target Selector, progesterone receptor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 10, 2018 Category: Pharmaceuticals Source Type: news

Halozyme Appoints Bernadette Connaughton To Board Of Directors
SAN DIEGO, Sept. 10, 2018 -- (Healthcare Sales & Marketing Network) -- Halozyme Therapeutics, Inc. (NASDAQ : HALO ), a biotechnology company developing novel oncology and drug-delivery therapies, today announced the appointment of Bernadette Connaughton t... Biopharmaceuticals, Oncology, Personnel Halozyme Therapeutics, pegvorhyaluronidase (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 10, 2018 Category: Pharmaceuticals Source Type: news

BioAtla Appoints Scott Smith As President
Experienced biopharmaceutical executive to drive expansion of operations, product strategy and corporate partnering efforts SAN DIEGO, Sept. 10, 2018 -- (Healthcare Sales & Marketing Network) -- BioAtla, LLC, a global biotechnology company focused on t... Biopharmaceuticals, Oncology, Personnel BioAtla , Conditionally Active Biologic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 10, 2018 Category: Pharmaceuticals Source Type: news

Medivir Appoints Dr. Linda Basse as Chief Medical Officer
STOCKHOLM, Sept. 10, 2018 -- (Healthcare Sales & Marketing Network) -- Medivir AB (Nasdaq Stockholm: MVIR) announced today it has appointed Linda Basse as Chief Medical Officer effective October 1, 2018. Dr. Basse will report to CEO Christine Lind and joi... Biopharmaceuticals, Oncology, Personnel Medivir, protease inhibitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 10, 2018 Category: Pharmaceuticals Source Type: news

Perrigo Announces Final FDA Approval and Planned Launch for the Store Brand OTC Equivalent of Imodium(R) Multi-Symptom Relief
DUBLIN, Sept. 7, 2018 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has received final approval from the U.S. Food & Drug administration for the store brand over-the-counter (OTC) equivalent of... Biopharmaceuticals, Generics, FDA, Product Launch Perrigo, Imodium, loperamide, simethicone (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2018 Category: Pharmaceuticals Source Type: news

Varian Signs Partnership Agreement with Mediheal to Support Cancer Care in Kenya
PALO ALTO, Calif. and NAIROBI, Kenya, Sept. 7, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE : VAR ) signed a partnership agreement with Mediheal Group of Hospitals to expand access to radiotherapy in Kenya. This comprehensive partnership... Devices, Oncology Varian Medical Systems, radiotherapy, linear accelerator, TrueBeam, Halcyon (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2018 Category: Pharmaceuticals Source Type: news

Optim Partners with 21st Century Oncology as the Preferred Vendor for Head and Neck Cancer Endoscopy
The ENTity™ XL Nasopharyngoscope has been selected by the leading health care provider as the preferred choice in technology utilized to diagnose and manage patients with head and neck cancers. STURBRIDGE, Mass., Sept. 7, 2018 -- (Healthcare Sales & Mar... Devices, Oncology Optim LLC, ENTityXL, Nasopharyngoscope, FreedomView, OptiLux (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2018 Category: Pharmaceuticals Source Type: news

BDD Pharma and Cingulate Therapeutics Announce License Agreement With OralogiK(TM) Enabled Triple Pulse Products
GLASGOW, Scotland, September 7, 2018 -- (Healthcare Sales & Marketing Network) -- BDD Pharma, a privately-owned drug delivery company specializing in the development of modified and controlled release oral formulations, and Cingulate Therapeutics, a clini... Biopharmaceuticals, Drug Delivery, Licensing BDD Pharma, Cingulate Therapeutics, OralogiK (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2018 Category: Pharmaceuticals Source Type: news

BD Statement on Divestiture of Advanced Bioprocessing Business
FRANKLIN LAKES, N.J., Sept. 7, 2018 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE : BDX ), a leading global medical technology company, today issued the following statement regarding the sale of its Advanced Bioproc... Devices, Diagnostics, Acquisitions BD , Thermo Fisher Scientific, Advanced Bioprocessing (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2018 Category: Pharmaceuticals Source Type: news

Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from BD
WALTHAM, Mass., Sept. 6, 2018 -- (Healthcare Sales & Marketing Network) -- Thermo Fisher Scientific Inc. (NYSE : TMO ), the world leader in serving science, has signed a definitive agreement with BD (Becton, Dickinson and Company –NYSE : BDX ), a leading ... Devices, Diagnostics, Acquisitions Thermo Fisher Scientific, BD , Advanced Bioprocessing (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2018 Category: Pharmaceuticals Source Type: news

Aileron Therapeutics Announces the Appointment of Dr. Manuel Aivado as Chief Executive Officer
WATERTOWN, Mass., Sept. 06, 2018 -- (Healthcare Sales & Marketing Network) -- Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases, today announced that Manuel Aivado, MD... Biopharmaceuticals, Oncology, Personnel Aileron Therapeutics, stapled peptides, alpha-helical peptides (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 6, 2018 Category: Pharmaceuticals Source Type: news

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Montelukast Tablets USP, 10mg 30Ct. due to product/label mix-up
PISCATAWAY, N.J., Sept. 6, 2018 -- (Healthcare Sales & Marketing Network) -- Camber Pharmaceuticals, Inc. is voluntarily recalling one single lot of Montelukast Sodium Tablets, USP 10mg, to the consumer level. This recall of one batch of Montelukast Sodiu... Biopharmaceuticals, FDA, Product Recall Camber Pharmaceuticals, Montelukast, Losartan (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 6, 2018 Category: Pharmaceuticals Source Type: news